2. Azuma A,Nukiwa T,Tsuboi E,et al. Double-blind,placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med,2005,171:1040-1047.
[2]
10. Shi Q,Liu X,Bai Y,et al. In vitro effects of pirfenidone on cardiac fibroblasts:proliferation,myofibroblast differentiation,migration and cytokine secretion. PLoS One,2011,6:e28134.
[3]
11. Noble PW,Albera C,Bradford WZ,et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY):two randomised trials. Lancet,2011,377:1760-1769.
[4]
12. Travis WD,Costabel U,Hansell DM,et al. An official American Thoracic Society/European Respiratory Society statement:Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med,2013,188:733-748.
1. ？Vancheri C,Failla M,Crimi N,et al. Idiopathic pulmonary fibrosis:a disease with similarities and links to cancer biology. Eur Respir J,2010,35:496-504.
[7]
3. Pecci A,Biino G,Fierro T,et al. Alteration of liver enzymes is a feature of the MYH9-related disease syndrome. PLoS One,2012,7:e35986.
[8]
4. King TE Jr,Bradford WZ,Castro-Bernardini S,et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med,2014,370:2083-2092.
[9]
5. Luppi F,Spagnolo P,Cerri S,et al. The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm Med,2012,18:428-432.
[10]
6. Liu Y. Hepatocyte growth factor in kidney fibrosis:therapeutic potential and mechanisms of action. Am J Physiol Renal Physiol,2004,287:F7-F16.
[11]
7. Navarro-Partida J,Martinez-Rizo AB,Gonzalez-Cuevas J,et al. Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis. Eur J Pharmacol,2012,678:71-77.
[12]
8. Suga H,Teraoka S,Ota K,et al. Preventive effect of pirfenidone against experimental sclerosing peritonitis in rats. Exp Toxicol Pathol,1995,47:287-291.
[13]
9. Hisatomi K,Mukae H,Sakamoto N,et al. Pirfenidone inhibits TGF-beta1-induced over-expression of collagen type Ⅰ and heat shock protein 47 in A549 cells. BMC Pulm Med,2012,12:24.
